Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, ...
Pfizer’s Albert Bourla put it more bluntly in Davos last month, saying it’s a “different world when you start discussing ...
Pharma groups like $113 bln Sanofi and Pfizer have spent years investing in immunisations. But scepticism from the US ...
The whiplash over a new potential flu vaccine from Moderna, which went from rejected to approved for review in a matter of days, has illustrated a new reality plaguing the Cambridge biotech company ...
Thousands of lawsuits in the U.S. allege that the agrochemical maker Bayer failed to warn people that its popular weedkiller ...
Industry and US administration leaders lay out their plans to navigate a globally competitive pharma landscape with China’s growing dominance.
Chinese pharmaceutical companies that as a group chalked up record outbound licensing agreements with international industry ...
Two of health secretary Robert F. Kennedy Jr.’s top lieutenants struck decidedly different tones at a forum held Tuesday by the pharmaceutical industry group PhRMA.
Federal policies under Robert F. Kennedy Jr. that are hostile to vaccines have “sent a chill through the entire industry,” one scientist said.
Alnylam Pharmaceuticals achieved profitability for the first time in its history in 2025. | Alnylam achieved profitability for the first time in its history in 2025. But disappointing sales ...
The FDA issued a rare Refusal-to-File letter to Moderna over its mRNA-based influenza vaccine application, in an unusual move that sent the biotech’s shares tumbling.
Pfizer Inc. (NYSE:PFE) is included among the Dividend Champions, Contenders, and Challengers List: 15 Highest Yielding Stocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results